Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
Danish Cancer Society
ClinicalTrials.gov Identifier:
NCT00932009
First received: June 30, 2009
Last updated: NA
Last verified: June 2009
History: No changes posted

June 30, 2009
June 30, 2009
March 2009
August 2009   (final data collection date for primary outcome measure)
HPV infection [ Designated as safety issue: No ]
Same as current
No Changes Posted
HIV infection
Same as current
Not Provided
Not Provided
 
Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men
Prevalence and Type Distribution of Genital Human Papillomavirus (HPV) in Tanzanian Men

The purpose of this study is to determine the prevalence and type distribution of genital human papillomavirus (HPV) infection in Tanzanian men.

Not Provided
Observational
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Not Provided
Retention:   Samples With DNA
Description:

cell scrapes from penis

Non-Probability Sample

Tanzanian men from an urban setting (Dar es Sallam)(factories, University, college)and men from an rural setting (Muhesa, Mwanga, Bagamoyo)

Human Papillomavirus Infection
Not Provided
Human papillomavirus
Tanzanian men with HPV and Tanzanian men without

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
2000
December 2009
August 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • men who are able to understand the information about the study (in writing or oral)

Exclusion Criteria:

-

Male
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT00932009
HPV IISP #36113
No
Susanne Krüger Kjaer/Professor, MD., DMSc., Institute of Cancer Epidemiology, Danish Cancer Society
Danish Cancer Society
Merck Sharp & Dohme Corp.
Principal Investigator: Susanne K. Kjaer, Professor, MD., DMSc. Inst. of Cancer Epidemiology,Danish Cancer Society
Danish Cancer Society
June 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP